---
title: "Kalbe’s Rp500 billion buyback faces a cash-conversion test"
description: "The balance sheet offers room for repurchases. Their contribution to earnings per share is modest beside the pressure on operating margins and cash after reinvestment."
author: "Trade Inc Research"
published_at: "2026-09-16T17:50:43.304Z"
updated_at: "2026-10-13T11:17:08Z"
canonical: "https://tradeinc.app/en/blog/klbf-rp500-billion-buyback-cash-flow-test-2026"
tickers: ["KLBF"]
citations: ["https://www.kalbe.co.id/api-content/File/GetFile/KLBF%20KI%20Buyback%20Tahap%209_final.pdf","https://www.idx.id/StaticData/NewsAndAnnouncement/ANNOUNCEMENTSTOCK/From_EREP/202609/a11448b9b3_5e1452d83c.pdf","https://www.idx.id/StaticData/NewsAndAnnouncement/ANNOUNCEMENTSTOCK/From_EREP/202607/20260731135305-63285-0/FinancialStatement-2026-II-KLBF.pdf","https://www.kalbe.co.id/api-content/File/GetFile/kalbe%20farma%20tbk_billingual_31_dec_2025_released.pdf","https://www.idx.id/StaticData/NewsAndAnnouncement/ANNOUNCEMENTSTOCK/From_EREP/202609/ca0d4e265b_fdcd26e326.pdf","https://www.kalbe.co.id/en/news/detail/maintaining-positive-double-digits-net-sales-growth-in-1h-2026-"]
---

# Kalbe’s Rp500 billion buyback faces a cash-conversion test

The balance sheet offers room for repurchases. Their contribution to earnings per share is modest beside the pressure on operating margins and cash after reinvestment.

Research updated: September 17, 2026, 00:30 WIB. Financial cutoff: June 30, 2026; share register: August 31, 2026; market reference: September 16 close. Assessment horizon: 12–24 months.

## Summary

Kalbe Farma’s proposed Rp500 billion share buyback is approximately 10.3% of its June cash balance, but the stronger investment case would require an improvement in the business behind those shares. The company’s own calculation puts the increase in earnings per share at just 1.16%, from Rp80.51 to Rp81.44, using 2025 earnings as its reference. [Buyback notice, September 16](https://www.kalbe.co.id/api-content/File/GetFile/KLBF%20KI%20Buyback%20Tahap%209_final.pdf)

The latest accounts explain why that distinction matters. First-half 2026 sales increased 14.0%, while profit attributable to shareholders declined 2.8%. Cash increased, but net bank borrowing exceeded the increase before currency effects. A repurchase can improve the ownership fraction of remaining shareholders; it cannot by itself restore margins or release cash tied up in operations. [First-half financial statements](https://www.idx.id/StaticData/NewsAndAnnouncement/ANNOUNCEMENTSTOCK/From_EREP/202607/20260731135305-63285-0/FinancialStatement-2026-II-KLBF.pdf)

## Key takeaways

- **Funding capacity:** the programme appears manageable against reported group cash, although freely available parent-company cash has not been established.
- **Operating performance:** H1 sales grew 14.0%, but attributable profit fell 2.8% as gross margin contracted. The [financial comparison](#sales-growth-is-not-translating-into-profit-growth) explains the divergence.
- **Cash quality:** net bank borrowing exceeded the increase in cash before currency effects. Operating cash after fixed and intangible investment also fell short of cash dividends. See the [cash bridge](#a-higher-cash-balance-does-not-mean-more-internally-generated-surplus).
- **Shareholder benefit:** management’s estimated EPS uplift is modest. Value creation depends on the purchase price relative to intrinsic value, not simply on reducing the share count.

## Contents

1. [Buyback terms](#the-final-notice-starts-the-programme-on-september-17)
2. [Financial performance](#sales-growth-is-not-translating-into-profit-growth)
3. [Cash generation and funding](#a-higher-cash-balance-does-not-mean-more-internally-generated-surplus)
4. [Working capital and earnings quality](#working-capital-needs-scrutiny-but-the-cause-is-not-settled)
5. [EPS sensitivity](#eps-accretion-is-small-and-depends-on-execution)
6. [Valuation implications](#value-creation-requires-buying-below-economic-value)
7. [Risks and what to monitor](#risks-and-what-to-monitor)
8. [Conclusion](#conclusion)
9. [Methodology and limitations](#methodology-and-limitations)

## The final notice starts the programme on September 17

Kalbe cancelled its September 15 announcement through a correction issued at 17:16 WIB, then filed a new notice on September 16. The signed replacement specifies September 17–December 17, 2026, subject to earlier termination. The earlier September 16–December 16 schedule should therefore not be used. [Cancellation filing](https://www.idx.id/StaticData/NewsAndAnnouncement/ANNOUNCEMENTSTOCK/From_EREP/202609/a11448b9b3_5e1452d83c.pdf), [replacement notice](https://www.kalbe.co.id/api-content/File/GetFile/KLBF%20KI%20Buyback%20Tahap%209_final.pdf)

The notice sets a maximum Rp500 billion allocation, funded internally, and transaction expenses of up to 0.1% of the repurchase value. Purchases are to take place on the Indonesia Stock Exchange through a broker. It gives no numerical purchase-price ceiling, referring instead to a price the company considers reasonable under applicable rules.

These are programme terms, not completed purchases. The notice also allows for future transfers of treasury shares. Investors should therefore monitor both execution and subsequent disposal; the programme does not promise permanent cancellation of every repurchased share.

## Sales growth is not translating into profit growth

| Consolidated metric | H1 2025 | H1 2026 | Change |
|---|---:|---:|---:|
| Revenue, Rp billion | 17,079.3 | 19,478.8 | +14.0% |
| Gross profit, Rp billion | 7,004.7 | 7,317.0 | +4.5% |
| Gross margin | 41.01% | 37.56% | −3.45 percentage points |
| Attributable profit, Rp billion | 1,974.9 | 1,919.5 | −2.8% |
| Operating cash flow, Rp billion | 1,301.3 | 1,254.7 | −3.6% |
| Operating cash flow / consolidated profit | 64.2% | 63.6% | −0.6 percentage points |

Source: Kalbe’s [unaudited H1 2026 filing](https://www.idx.id/StaticData/NewsAndAnnouncement/ANNOUNCEMENTSTOCK/From_EREP/202607/20260731135305-63285-0/FinancialStatement-2026-II-KLBF.pdf), including its H1 2025 comparatives; Trade, Inc. calculations. Cash conversion uses total consolidated profit, matching the scope of group cash flow, rather than attributable profit.

Revenue growth delivered only a 4.5% increase in gross profit as cost of sales rose faster than revenue. Management attributes the margin pressure to raw-material prices, rupiah depreciation, and product mix, while describing volume growth and additional external-principal business as revenue drivers. Those are management’s explanations; the published totals do not quantify each driver’s contribution. [Kalbe’s July 31 results release](https://www.kalbe.co.id/en/news/detail/maintaining-positive-double-digits-net-sales-growth-in-1h-2026-)

The scale matters. At the reported half-year revenue, one percentage point of gross margin represents approximately Rp194.8 billion of gross profit before any change in operating expenses or tax. That is a sensitivity, not an earnings forecast. It illustrates why small changes in operating economics can outweigh the buyback’s modest EPS benefit.

## A higher cash balance does not mean more internally generated surplus

Cash and equivalents increased from Rp4,331.4 billion at December 2025 to Rp4,831.8 billion at June 2026. The following bridge reconciles the increase.

| H1 2026 movement | Rp billion |
|---|---:|
| Operating cash flow | +1,254.680 |
| Net investing cash flow | −307.553 |
| Cash dividends paid by the group | −946.363 |
| Net treasury-share purchases | −43.988 |
| Interest, lease payments and other financing outflows | −28.135 |
| Bank borrowings less bank repayments | +515.700 |
| Increase before currency effects | **+444.341** |
| Currency effects | +56.050 |
| Increase in cash and equivalents | **+500.391** |

Source: [H1 2026 cash-flow statement](https://www.idx.id/StaticData/NewsAndAnnouncement/ANNOUNCEMENTSTOCK/From_EREP/202607/20260731135305-63285-0/FinancialStatement-2026-II-KLBF.pdf). Subtotals are not additional cash flows.

Without net bank borrowing, the other reported flows sum to a Rp71.4 billion cash decrease before currency effects. This accounting decomposition does not prove that a particular bank loan funded shareholder distributions: consolidated flows do not trace individual funding decisions within each entity. It does show why the cash balance alone overstates the evidence for a growing distributable surplus.

A narrower operating measure tells the same story. Operating cash flow less purchases of fixed and intangible assets was Rp829.1 billion. That was below Rp946.4 billion of cash dividends, before Rp44.0 billion of net treasury-share purchases. This measure excludes acquisitions, asset-sale proceeds, investment income, financing costs and other investing flows; it is not a complete measure of cash available to the parent.

Reported cash nevertheless provides a meaningful cushion. A hypothetical immediate Rp500 billion outlay against the June balance would leave Rp4,331.8 billion before fees and subsequent cash movements. That is a static funding illustration, not September liquidity guidance. The consolidated balance does not establish how much cash is immediately transferable to the parent after subsidiary needs and commitments.

## Working capital needs scrutiny, but the cause is not settled

Between December and June, trade receivables rose Rp931.4 billion and inventories increased Rp938.6 billion. Trade payables rose Rp548.6 billion, partly offsetting those increases. Receivables plus inventories less trade payables therefore expanded by Rp1,321.4 billion. [H1 balance sheet](https://www.idx.id/StaticData/NewsAndAnnouncement/ANNOUNCEMENTSTOCK/From_EREP/202607/20260731135305-63285-0/FinancialStatement-2026-II-KLBF.pdf)

This is a balance-sheet comparison, not an exact cash-flow attribution: currency translation, provisions and other non-cash changes can affect balances. Nor does the increase, by itself, demonstrate slower collections. A growing distribution business and precautionary stocking could legitimately require more working capital. Seasonality also makes June-versus-December growth an incomplete test of efficiency.

There is a useful caution in the earlier annual numbers. In 2025, attributable profit increased 13.1%, but operating cash flow fell 31.7%. Cash receipts less payments to suppliers and employees improved by Rp74.6 billion. However, payments for other operating expenses increased Rp1,491.3 billion, and income taxes paid net of refunds increased Rp97.9 billion. Together these reconcile the Rp1,514.5 billion operating cash-flow decline. The broad expense category needs explanation before attributing the full deterioration to receivables or inventory. [Audited 2025 accounts, statements pp. 5 and 7–8](https://www.kalbe.co.id/api-content/File/GetFile/kalbe%20farma%20tbk_billingual_31_dec_2025_released.pdf)

The next test is whether inventory and receivables normalise relative to sales while margins stabilise. Persistent cash absorption without a corresponding improvement in operating returns would weaken the case for repeated repurchases.

## EPS accretion is small and depends on execution

The August register reports 46.813 billion issued shares, including 1.565 billion treasury shares. The resulting non-treasury count is 45.249 billion. At the September 16 closing price of Rp760, a Rp500 billion purchase would acquire about 657.9 million shares, or 1.45% of that count, before fees and market impact. The closing price is a reference, not an achievable average execution price. [August share register](https://www.idx.id/StaticData/NewsAndAnnouncement/ANNOUNCEMENTSTOCK/From_EREP/202609/ca0d4e265b_fdcd26e326.pdf); Trade, Inc. closing-price data.

The sensitivity below holds annual attributable profit at its FY2025 level of Rp3,665.0 billion and applies the August non-treasury share count. It assumes a full Rp500 billion repurchase and a full year of foregone after-tax cash income. Each percentage compares post-buyback EPS with the same hypothetical earnings and share-count baseline before repurchase.

| Purchase price | Shares, million | EPS: 3% yield | EPS: 5% yield | EPS: 7% yield |
|---|---:|---:|---:|---:|
| Rp650 | 769.2 | +1.31% | +1.04% | +0.76% |
| Rp760 | 657.9 | +1.06% | +0.78% | +0.51% |
| Rp900 | 555.6 | +0.83% | +0.55% | +0.28% |

Source: Trade, Inc. scenario calculations using the audited accounts and August register. Prices and cash yields are assumptions; fees and execution timing are excluded. The annual opportunity cost is Rp15 billion, Rp25 billion or Rp35 billion respectively.

Kalbe separately estimates Rp8.4 billion of lost interest income and Rp81.44 pro forma EPS. Its three-page notice does not disclose enough detail on assumed execution price, interest horizon, tax treatment and share weighting to reproduce that result uniquely. We therefore present it as management’s estimate, separately from our annual sensitivity. Actual reported EPS will depend on weighted-average shares and the purchase dates.

## Value creation requires buying below economic value

At Rp760, the stock trades at approximately 9.4 times reported FY2025 EPS of Rp80.51. This is a historical earnings multiple, not a forward valuation. It says little by itself about sustainable margins or the cash needed to sustain growth.

Even an EPS-accretive buyback can reduce value if the company overpays. To isolate this mechanism, assume Rp500 billion is spent at Rp760 and use the August non-treasury share count. If the shares were worth Rp700 before the repurchase, the transaction would reduce value per remaining share by about Rp0.89. At assumed pre-buyback values of Rp900 and Rp1,100, it would add about Rp2.07 and Rp5.02 respectively.

These are illustrative intrinsic-value assumptions, not price targets. The calculation deducts the cash spent from total equity value and divides by the reduced share count, holding all other business value constant. It shows that the direct value transfer is relatively small at this programme size. A defensible valuation still requires a forecast of segment margins, reinvestment and distributable cash; no such forecast is implied here.

## Risks and what to monitor

The next two financial reporting cycles should help distinguish a temporary operating squeeze from a more persistent reduction in cash generation. Over the 12–24-month assessment horizon, the following evidence would change our view:

| Area to monitor | Evidence that strengthens the case | Evidence that weakens the case |
|---|---|---|
| Operating margins | Gross margin stabilises as revenue grows | Cost pressure continues to absorb sales growth |
| Cash and working capital | Cash after fixed and intangible investment covers distributions; receivables and inventories ease relative to activity | Working capital keeps absorbing cash; borrowing repeatedly accompanies distributions |
| Buyback execution | Actual purchases occur at prices supported by sustainable cash-flow prospects | Execution prices lack valuation support, or treasury shares are later transferred on unattractive terms |

These are analytical watchpoints, not company guidance. A short-term share-price rise would not, on its own, confirm the investment case.

## Conclusion

Kalbe has reported liquidity that can support the proposed buyback, but the programme’s modest EPS effect does not materially resolve the pressure on operating performance. Our assessment is that the announcement deserves limited weight in the investment thesis until margin recovery and cash generation provide stronger support.

The decision rule is to assess the repurchase alongside cash left after reinvestment and the price paid for each share. Improving cash coverage and disciplined execution would strengthen the case; persistent margin pressure and recurring borrowing alongside distributions would weaken it. The evidence reviewed does not establish that KLBF trades below intrinsic value, so this note assigns neither a rating nor a price target.

## Methodology and limitations

All figures are consolidated unless stated otherwise. Financial-statement amounts in millions of rupiah are converted to billions; EPS and purchase prices remain rupiah per share. H1 means January–June, and comparatives come from the same filing. No half-year number is treated as a full-year forecast.

Cash conversion equals operating cash flow divided by consolidated profit. Operating cash after investment equals operating cash flow less cash purchases of fixed and intangible assets, without netting asset disposals. Working capital here is limited to trade receivables plus inventory less trade payables.

For EPS sensitivity, with earnings E, non-treasury shares N, budget B, price P and annual after-tax cash yield y, post-buyback EPS is (E − B × y) / (N − B / P). Inputs use consistent rupiah units. For value sensitivity, post-buyback value per share is (N × V − B) / (N − B / P), where V is assumed pre-buyback intrinsic value including cash. Both are static illustrations, excluding fees, price impact, new issuance and subsequent treasury-share transfers.

The study verifies announced terms, historical accounts and the share register. It does not verify execution after the September 16 close, unrestricted parent-company cash, a complete bridge for the broad operating-expense cash line, or a forward intrinsic valuation. Those limits constrain the conclusion rather than being filled with assumed forecasts.


[1]: https://www.kalbe.co.id/api-content/File/GetFile/KLBF%20KI%20Buyback%20Tahap%209_final.pdf "Kalbe: signed buyback notice, 16 September 2026 (pp. 1–3)"
[2]: https://www.idx.id/StaticData/NewsAndAnnouncement/ANNOUNCEMENTSTOCK/From_EREP/202609/a11448b9b3_5e1452d83c.pdf "IDX: cancellation/correction, 068/CSEC-KF/IX-2026"
[3]: https://www.idx.id/StaticData/NewsAndAnnouncement/ANNOUNCEMENTSTOCK/From_EREP/202607/20260731135305-63285-0/FinancialStatement-2026-II-KLBF.pdf "Kalbe: unaudited H1 2026 statements and H1 2025 comparatives"
[4]: https://www.kalbe.co.id/api-content/File/GetFile/kalbe%20farma%20tbk_billingual_31_dec_2025_released.pdf "Kalbe: audited FY2025 statements, statements pp. 1–8; EPS note 42"
[5]: https://www.idx.id/StaticData/NewsAndAnnouncement/ANNOUNCEMENTSTOCK/From_EREP/202609/ca0d4e265b_fdcd26e326.pdf "IDX: Kalbe August 2026 share register, filed 7 September"
[6]: https://www.kalbe.co.id/en/news/detail/maintaining-positive-double-digits-net-sales-growth-in-1h-2026- "Kalbe: H1 2026 results announcement, 31 July 2026"